Global Animal Model Market Growth at 6.11% CAGR | Key Insights & Forecast
The global animal model market has seen significant growth in recent years, driven by increasing demand for animal models in drug development, basic research, and academic studies. According to Straits Research, the animal model market size was valued at USD 2.24 billion in 2023 and is projected to reach USD 2.37 billion in 2024, growing to USD 3.60 billion by 2032, at a CAGR of 6.11% during the forecast period (2024–2032). This growth is being fueled by the increasing need for preclinical testing in the pharmaceutical and biotechnology industries, advancements in animal model technology, and the growing focus on personalized medicine.
Drivers in the Animal Model Market
Several factors are driving the expansion of the animal model market, especially within the fields of drug discovery, biotech research, and genetic studies. Some key drivers include:
Rising Pharmaceutical and Biotechnology Investments: Pharmaceutical companies continue to increase investments in drug discovery, with animal models serving as essential tools in preclinical testing. As the need for novel drugs increases, the demand for animal models that accurately represent human diseases is growing.
Technological Advancements: Animal model technology has evolved with the development of genetically modified models, including transgenic animals, and the adoption of advanced imaging techniques. These innovations allow for more precise studies and better alignment with human biology.
Expanding Preclinical Research: The importance of animal models in the early stages of drug development cannot be overstated. As researchers continue to focus on understanding disease mechanisms and testing new therapies, animal models are essential in ensuring drug safety and efficacy.
Increasing Number of Research Projects: With the growing complexity of diseases and medical conditions, academic research institutions are increasing their use of animal models to conduct basic research. This trend is contributing to the demand for various animal types, especially rodents and rabbits, for a wide range of studies.
Regulatory Push for Animal Testing: Many countries continue to mandate animal testing for drug approval, further pushing the demand for animal models in pharmaceutical companies and biotech labs. The FDA and similar regulatory bodies require preclinical data from animal models before human clinical trials can begin.
Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/report/animal-model-market/request-sample
Key Developments in the Animal Model Market
The animal model market is evolving with several innovations and strategic movements by key players. These include:
Expansion of Animal Model Offerings: Leading companies are increasingly offering specialized animal models designed for specific diseases such as cancer, cardiovascular diseases, and neurological disorders. These models are gaining popularity due to their high relevance in current therapeutic research.
Increased Focus on Ethical Standards: Companies are making significant strides toward improving the ethical treatment of animals in research. The market is seeing increased adoption of alternative models that reduce the need for animals in testing, like 3D cell cultures and organ-on-chip technologies.
Partnerships and Collaborations: Leading players in the animal model market are forming strategic partnerships and acquisitions to expand their portfolios and enhance their capabilities. For instance, collaboration with academic institutions and biotech firms ensures the availability of the most relevant models for research purposes.
Geographic Expansion: Key companies are expanding their reach into emerging markets, where there is growing demand for animal models in research and drug development. These regions include Asia-Pacific, where biotechnology research and pharmaceutical investment are rising steadily.
Top Key Players in the Animal Model Market
Several leading companies are making substantial contributions to the animal model market by providing innovative solutions and models for research and development purposes. These key players include:
- Charles River Laboratories
- The Jackson Laboratory
- Genoway S.A
- Taconic Biosciences, Inc.
- Janvier Labs
- Harbour BioMed
- Crown Bioscience
- Envigo RMS, LLC
- Inotiv
- BIOCYTOGEN
- BioSpherix, Ltd.
- Ozgene Pty
- Trans Genic Inc
- Hera Biolabs
- B&K Universal
These companies are at the forefront of developing high-quality, genetically modified animal models and providing services for both academic and commercial clients.
Segmentation Analysis of the Animal Model Market
The animal model market is categorized into various segments based on animal type, application, and end-user. The segmentation of the market helps in understanding the different dynamics within the industry and provides valuable insights into current trends and opportunities.
By Animal Type
- Rat: Widely used in cancer, diabetes, and cardiovascular disease studies.
- Mice: The most commonly used animal in research due to their genetic similarity to humans.
- Guinea Pigs: Often used for toxicology testing and drug efficacy studies.
- Rabbits: Used in vaccine testing, dermatology studies, and ophthalmology.
- Others: Includes other species such as primates and pigs, depending on the nature of the research.
By Application
- Drug Discovery and Development: Animal models are essential in testing the safety and efficacy of new drugs before human clinical trials.
- Basic Research: Researchers use animal models to study disease mechanisms, genetic research, and potential treatments.
- Others: Includes education, toxicity testing, and other specialized applications.
By End-User
- Pharma and Biotech Companies: These companies are the largest consumers of animal models for drug discovery and development.
- Academic Research Institutes: Universities and research labs often use animal models to conduct basic and applied research.
- Others: Includes contract research organizations (CROs) and testing labs.
Animal Model Market Emerging Prospects
The future of the animal model market looks promising, driven by increasing research funding, advancements in technology, and growing global pharmaceutical investments. Emerging prospects include the increased adoption of genetically modified models, the growing emphasis on personalized medicine, and the expansion of research into new disease areas like neurodegenerative disorders and rare diseases.
Animal Model Market Industry Movements
The market is expected to see continued consolidation, with leading companies acquiring smaller firms to expand their product offerings and enhance their research capabilities. Additionally, virtual animal models and computational biology are gaining traction as alternatives to traditional animal testing methods, potentially disrupting the market.
Animal Model Market Geographic Analysis
North America currently holds the largest share of the animal model market, driven by high research funding, pharmaceutical investments, and strong regulatory requirements. However, regions such as Asia-Pacific are expected to witness rapid growth due to rising healthcare investments, increased pharmaceutical research, and expanding biotechnology sectors.
Animal Model Market Data Insights
Straits Research offers comprehensive insights into the animal model market, providing in-depth analysis of the trends, key players, and market dynamics that shape this fast-growing sector. This report is an essential resource for stakeholders aiming to stay competitive and capitalize on emerging opportunities.
Contact Us:
Email: sales@straitsresearch.com
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Address: 825 3rd Avenue, New York, NY, USA, 10022